SUBSCRIBE TO OUR FREE NEWSLETTER
Daily news & progressive opinion—funded by the people, not the corporations—delivered straight to your inbox.
5
#000000
#FFFFFF
5
#000000
#FFFFFF
centers for medicare and medicaid services
Watchdogs Renew Warnings of 'Profoundly Unqualified' Dr. Oz After Senate Hearing
"Between his massive conflicts of interest across the healthcare sector and his endorsement of further privatizing Medicare, Oz would be a threat to the health of tens of millions of Americans," said one opponent.
Mar 14, 2025
Progressive watchdog organizations responded to the U.S. Senate Finance Committee's Friday hearing for Dr. Mehmet Oz by again sounding the alarm about the heart surgeon and former television host nominated to lead a key federal healthcare agency.
Since President Donald Trumpannounced Oz as his nominee for administrator of the Centers for Medicare and Medicaid Services (CMS) last November, opponents have spotlighted the doctor's promotion of unproven products, investments in companies with interests in the federal agency, and support for expanding Medicare Advantage during an unsuccessful U.S. Senate run in 2022.
"Dr. Oz's career promoting dubious medical treatments and pseudoscience often for personal financial gain should immediately disqualify him from serving in any public health capacity, let alone in a top administration health post," Accountable.US executive director Tony Carrk said in a Friday statement.
"Dr. Oz's nomination is part of President Trump's grand plan to enrich his corporate donors and wealthy friends while the rest of us get higher costs, less coverage, and weakened protections."
In December, Carrk's group found that based on disclosures from Oz's 2022 run against U.S. Sen. John Fetterman (D-Pa.), the Republican doctor reported "up to $56 million in investments in three companies" with direct CMS interests—including Sharecare, which became the "exclusive in-home care supplemental benefit program" for 1.5 million Medicare Advantage enrollees.
A spokesperson said at the time that Oz has since divested from Sharecare. However, critics have still expressed concern about how the nominee's confirmation could boost Republican efforts to expand Medicare Advantage—health insurance plans for seniors administered by private companies rather than the government.
"As a self-interested advocate of privatizing Medicare at a higher cost and more denials of care for seniors, Dr. Oz is surely eager to enact the Trump-Republican budget plan to gut Medicare and Medicaid and jeopardize health coverage for millions of Americans—all to pay for more tax breaks for billionaires and price gouging corporations," said Carrk. "Dr. Oz's nomination is part of President Trump's grand plan to enrich his corporate donors and wealthy friends while the rest of us get higher costs, less coverage, and weakened protections—especially those with preexisting conditions."
As he faces Senate confirmation, remember that Dr. Oz: -Pushed Medicare privatization plans on his show -Owns ~$600k in stock in private insurers -Has ties to pyramid scheme companies that promote fake medical cures His main qualification to oversee CMS is loyalty to Trump.
— Robert Reich ( @rbreich.bsky.social) March 14, 2025 at 1:41 PM
Robert Weissman, co-president of the consumer advocacy group Public Citizen, has been similarly critical of Oz, and remained so after senators questioned him on Friday, saying in a statement that "Mehmet Oz showed he is profoundly unqualified to lead any part of our healthcare system, let alone an agency as important as CMS."
"Between his massive conflicts of interest across the healthcare sector and his endorsement of further privatizing Medicare, Oz would be a threat to the health of tens of millions of Americans," Weissman warned. "Privatized Medicare Advantage plans deliver inferior care and cost taxpayers nearly $100 billion annually in excess costs."
"It is time for President Trump to put down the remote, stop finding nominees on television, and instead nominate people with actual experience and a belief in the importance of protecting crucial health programs like Medicare and Medicaid," he argued, taking aim at not only the president but also his billionaire adviser Elon Musk, head of the so-called Department of Government Efficiency and, Robert F. Kennedy Jr., the conspiracy theorist now running the Department of Health and Human Services.
Weissman declared that "Trump, Musk, and RFK Jr. fail to put the American people first as they seek to gut agencies and make dangerous cuts to health programs to fund tax cuts for billionaires. Oz indicated he would not oppose such cuts, bringing more destruction to lifesaving programs. Oz has no place in government and should be roundly rejected by every senator."
During a Friday exchange with Sen. Ron Wyden (D-Ore.), the committee's ranking member, Oz refused to decisively commit to opposing cuts to Medicaid. As the Alliance for Retired Americans highlighted, Oz kept that up when given opportunities to revise his answer by Sens. Ben Ray Luján (D-N.M.) and Michael Bennet (D-Colo.).
Other moments from the hearing that garnered attention included Oz's exchange with Sen. Catherine Cortez Masto (D-Nev.) about Affordable Care Act tax credits and Sen. Maggie Hassan (D-N.H.) calling out the doctor for his unwillingness "to take accountability for" his "promotion of unproven snake oil remedies" to millions of TV viewers.
Keep ReadingShow Less
Warren Urges Medicare Nominee Oz to 'Divest From Financial Conflicts of Interest'
"By making these commitments, you would increase Americans' trust in your ability to serve the public interest during your time at CMS—rather than the special interests of companies in your network."
Mar 12, 2025
U.S. Sen. Elizabeth Warren on Wednesday called on Dr. Mehmet Oz, President Donald Trump's nominee to head the federal agency in charge of Medicare, to divest all financial ties to Big Pharma and healthcare companies in order to avoid conflicts of interest and gain the public's trust.
"Congratulations on your nomination to serve as administrator of the Centers for Medicare and Medicaid Services (CMS)," Warren (D-Mass.) wrote in a letter to the celebrity heart surgeon and erstwhile purveyor of phony weight loss cures. "If confirmed, you will be expected to steward CMS' $1.5 trillion budget in the best interest of the over 140 million Americans on Medicare and Medicaid. Entering this role with financial conflicts of interest would undermine your effectiveness and the effectiveness of the programs you are slated to administer."
"To avoid this, I request that you agree to: divest any remaining financial interests in health-related companies or patents that you will have the power to influence, recuse from matters involving your former employers and clients, and, for at least four years after you leave office, not lobby CMS or join the industries that depend on CMS' work," the senator said.
"Entering this role with financial conflicts of interest would undermine your effectiveness and the effectiveness of the programs you are slated to administer."
"By making these commitments, you would increase Americans' trust in your ability to serve the public interest during your time at CMS—rather than the special interests of companies in your network," she added.
"You have deep ties to companies that could profit from your decisions at CMS," Warren noted. "You currently serve as a managing member or adviser of multiple healthcare and pharmaceutical firms with a financial stake in CMS policy, including how the agency sets payment rates and coverage determinations for Medicare and Medicaid."
Warren continued:
You also use your public platforms—including your website, TV show, TikTok, and Instagram pages—to promote drugs, such as Ozempic, produced by pharmaceutical companies that are currently seeking expanded CMS coverage approval and that are subject to government drug negotiations—which you would be responsible for conducting. You have been paid to push your show's viewers to enroll in the private alternative to Medicare, Medicare Advantage—a program run by private health insurers that overcharged CMS by at least $83 billion in 2024 alone.
Doctors have critiqued you for allegedly "promoting quack treatments and cures in the interest of personal financial gain." Furthermore, much of your financial portfolio (worth at least $98 million) is invested in healthcare and pharmaceutical companies whose value is tied to CMS' regulatory work.
Last December, the watchdog Accountable.US revealed that Oz had invested as much as $56 million in three companies with direct CMS interests. In 2022, Oz's single biggest healthcare holding was up to $26 million in Sharecare, a digital health company Oz co-founded, and which became the exclusive in-home supplemental care program for 1.5 million Medicare Advantage customers.
On Tuesday, the consumer advocacy group Public Citizen published a research brief examining the hundreds of millions of dollars spent on political lobbying by Medicare Advantage companies ahead of Oz's confirmation hearing, which is scheduled for Friday morning.
Warren and other Democratic lawmakers previously pressed Oz on his advocacy for Medicare privatization, including a 2020 call for enrolling all U.S. seniors in Medicare Advantage plans.
Last month, Oz pledged to divestfrom insurance companies and drugmakers and step down from his advisory positions if his nomination is confirmed.
"I appreciate that you have agreed to divest much of your portfolio and resign from your advisory posts," Warren wrote. "Still, given your close ties to the industry that you would regulate, if you are confirmed, the public would have reason to question your impartiality and commitment to serving the public's interest."
Keep ReadingShow Less
Rampant Medicare Advantage Fraud Is Staring Musk in the Face. Critics Predict He'll Ignore It
"I'll bet Elon and the DOGE boys can't find Medicare Advantage," quipped one economist. "You know these people were not hired on merit."
Feb 06, 2025
Privatized Medicare Advantage plans overbill the U.S. federal government by up to $140 billion per year as they make patients appear sicker than they actually are to rake in more taxpayer money.
It didn't take a team of inexperienced engineers combing through the complex and sensitive inner workings of government payment systems to reach that conclusion, but that's reportedly what Elon Musk's lieutenants are now doing at the Centers for Medicare and Medicaid Services (CMS) with the stated goal of locating and combatting "fraud."
On Wednesday, The Wall Street Journalreported that representatives of the so-called "Department of Government Efficiency" (DOGE) have gained "access to key payment and contracting systems" at CMS with an eye toward "pinpointing what they consider fraud or waste."
Precisely what Musk and his lackeys see as fraud, and whether pervasive Medicare Advantage overbilling fits their definition, is unclear. In a post to his social media platform on Wednesday, Musk claimed—without elaborating or providing any evidence—that CMS is "where the big money fraud is happening."
But critics expressed doubt that Medicare Advantage, a huge cash cow for private insurers that's supported by President Donald Trump and congressional Republicans, will become a focal point of Musk's austerity blitz.
"You don't have to search payment systems for Medicare fraud, you could turn to the latest published report from the Medicare Payment Advisory Commission which helpfully lists $83 billion in annual fraud payments," The American Prospect's David Dayen wrote Wednesday. "The unnecessary overpayments are all made to private insurers in Medicare Advantage, the privatization of Medicare. We found the money!"
"Alternatively, if you're hunting for Medicare fraud you could go to the office of Senator Rick Scott," Dayen added, referring to the Florida Republican whose healthcare firm committed large-scale Medicare and Medicaid fraud.
Last month, Dayen noted that a crackdown on Medicare Advantage is "an unlikely avenue for DOGE" given that Mehmet Oz—who campaigned for the U.S. Senate on a plan dubbed "Medicare Advantage for All"—is poised to lead CMS.
Nor has Robert F. Kennedy Jr., who is on track for Senate confirmation to lead the department that oversees CMS, expressed any interest in tackling Medicare Advantage fraud. During his confirmation hearing last week, Kennedy failed to correctly answer basic questions about Medicare, including Medicare Part C—also known as Medicare Advantage.
Dean Baker, a senior economist at the Center for Economic and Policy Research, quipped Thursday that "I'll bet Elon and the DOGE boys can't find Medicare Advantage."
"You know these people were not hired on merit," he added.
In a blog post on Wednesday, Baker pushed back on the view that "Musk and his crew somehow want a world without government," writing that in reality they simply "don't want government social programs that help people who are not rich."
"Musk's view is that the government should only be there to make him and his fellow billionaires richer," Baker wrote. "We could have a much more efficient insurance system if we had Medicare for All, but that would wipe out the private insurance industry. Instead, we are going the other way and whittling down traditional Medicare and increasing costs by pushing people back to private insurers with Medicare Advantage."
"It is absurd that people on the left have allowed the Musk billionaire libertarians of the world to pretend they are anti-government," Baker added. "They just want a government that only serves their interest rather than society as a whole."
Keep ReadingShow Less
Most Popular